These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33394998)

  • 1. MONTHLY INTRAVITREAL INFLIXIMAB IN BEHÇET'S DISEASE ACTIVE POSTERIOR UVEITIS: A Long-Term Safety Study.
    Refaat M; Abdullatif AM; Hamza MM; Macky TA; El-Agha MH; Ragab G; Soliman MM
    Retina; 2021 Aug; 41(8):1739-1747. PubMed ID: 33394998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal infliximab for sight-threatening relapsing uveitis in Behçet disease: a pilot study in 15 patients.
    Markomichelakis N; Delicha E; Masselos S; Sfikakis PP
    Am J Ophthalmol; 2012 Sep; 154(3):534-541.e1. PubMed ID: 22789563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.
    Niccoli L; Nannini C; Benucci M; Chindamo D; Cassarà E; Salvarani C; Cimino L; Gini G; Lenzetti I; Cantini F
    Rheumatology (Oxford); 2007 Jul; 46(7):1161-4. PubMed ID: 17478466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab in the treatment of posterior uveitis in Behçet's disease. Long term follow up in four patients.
    Lanthier N; Parc C; Scavennec R; Dhôte R; Brézin AP; Guillevin L
    Presse Med; 2005 Jul; 34(13):916-8. PubMed ID: 16142147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term remission of ocular and extraocular manifestations in Behçet's disease using infliximab.
    Handa T; Tsunekawa H; Yoneda M; Watanabe D; Mukai T; Yamamura M; Iwaki M; Zako M
    Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S58-63. PubMed ID: 21968238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of infliximab in the treatment of refractory posterior uveitis of Behçet's disease after withdrawal of infusions.
    Adán A; Hernandez V; Ortiz S; Molina JJ; Pelegrin L; Espinosa G; Sanmartí R
    Int Ophthalmol; 2010 Oct; 30(5):577-81. PubMed ID: 20490893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes in patients with refractory uveitis associated with Behçet disease treated with infliximab.
    Al Rashidi S; Al Fawaz A; Kangave D; Abu El-Asrar AM
    Ocul Immunol Inflamm; 2013 Dec; 21(6):468-74. PubMed ID: 23734940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years.
    Davatchi F; Sadeghi Abdollahi B; Shams H; Shahram F; Nadji A; Chams-Davatchi C; Faezi T; Akhlaghi M; Ghodsi Z; Ashofteh F; Mohtasham N
    Int J Rheum Dis; 2014 May; 17(4):444-52. PubMed ID: 24314325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.
    Kötter I; Zierhut M; Eckstein AK; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Meyer-Riemann W; Peter HH; Stübiger N
    Br J Ophthalmol; 2003 Apr; 87(4):423-31. PubMed ID: 12642304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
    Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INTRAVITREAL INFLIXIMAB IN REFRACTORY UVEITIS IN BEHCET'S DISEASE: A Safety and Efficacy Clinical Study.
    Hamza MM; Macky TA; Sidky MK; Ragab G; Soliman MM
    Retina; 2016 Dec; 36(12):2399-2408. PubMed ID: 27870802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).
    Benitez-del-Castillo JM; Martinez-de-la-Casa JM; Pato-Cour E; Méndez-Fernández R; López-Abad C; Matilla M; Garcia-Sanchez J
    Eye (Lond); 2005 Aug; 19(8):841-5. PubMed ID: 15389273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate in ocular manifestations of Behcet's disease: a longitudinal study up to 15 years.
    Davatchi F; Shams H; Shahram F; Nadji A; Chams-Davatchi C; Sadeghi Abdollahi B; Faezi T; Akhlaghi M; Ashofteh F
    Int J Rheum Dis; 2013 Oct; 16(5):568-77. PubMed ID: 24164845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal Dexamethasone Implant for Treatment of Refractory Behçet Posterior Uveitis: One-year Follow-up Results.
    Coşkun E; Celemler P; Kimyon G; Öner V; Kisacik B; Erbagci I; Onat AM
    Ocul Immunol Inflamm; 2015; 23(6):437-43. PubMed ID: 26470764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of intravitreal triamcinolone acetonide injection for the treatment of uveitis attacks in Behçet disease.
    Park UC; Park JH; Yu HG
    Ocul Immunol Inflamm; 2014 Feb; 22(1):27-33. PubMed ID: 24063666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behçet's disease: a comparative 4-week study.
    Markomichelakis N; Delicha E; Masselos S; Fragiadaki K; Kaklamanis P; Sfikakis PP
    Rheumatology (Oxford); 2011 Mar; 50(3):593-7. PubMed ID: 21097877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.
    Takeuchi M; Kezuka T; Sugita S; Keino H; Namba K; Kaburaki T; Maruyama K; Nakai K; Hijioka K; Shibuya E; Komae K; Hori J; Ohguro N; Sonoda KH; Mizuki N; Okada AA; Ishibashi T; Goto H; Mochizuki M
    Ophthalmology; 2014 Oct; 121(10):1877-84. PubMed ID: 24950593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behçet's disease.
    Ishikawa S; Taguchi M; Muraoka T; Sakurai Y; Kanda T; Takeuchi M
    Br J Ophthalmol; 2014 Nov; 98(11):1508-13. PubMed ID: 24939422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-TNF-alpha therapy for sight threatening uveitis.
    Lindstedt EW; Baarsma GS; Kuijpers RW; van Hagen PM
    Br J Ophthalmol; 2005 May; 89(5):533-6. PubMed ID: 15834077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of a single dose of infliximab in the treatment of Behçet's disease uveitis.
    Arayssi T; Hamra R; Homeidan F; Uthman I; Awwad ST; Mroue K; Mansour W; Bashshur ZF
    Clin Exp Rheumatol; 2005; 23(3):427. PubMed ID: 15971438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.